As triglycerides are also known to accumulate in dysfunctional melanoma-associated DC (165), silencing of IRE1α or XBP1 expression in these cells might also improve DC-mediated immune responses against this cancer in certain contexts. The gene discussed is XBP1; the disease is melanoma.